Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 23583
Gene Symbol: SMUG1
SMUG1
0.050 Biomarker disease BEFREE We retrospectively examined pretreatment F-FDG PET/CT images obtained from 85 patients with nonmetastatic SGC showing high-risk histology. 30932974 2019
Entrez Id: 23583
Gene Symbol: SMUG1
SMUG1
0.050 Biomarker disease BEFREE The texture analysis of pretreatment [<sup>18</sup>F]FDG PET/CT provided more information than conventional PET parameters for predicting patient prognosis of locally advanced salivary gland carcinoma treated with interstitial brachytherapy. 31511990 2019
Entrez Id: 23583
Gene Symbol: SMUG1
SMUG1
0.050 Biomarker disease BEFREE Up-front F18-FDG PET/CT in suspected salivary gland carcinoma. 31102059 2019
Entrez Id: 23583
Gene Symbol: SMUG1
SMUG1
0.050 Biomarker disease BEFREE We conducted a 2-center, retrospective study on 117 patients with salivary gland carcinoma who underwent F-FDG PET/CT before treatment and were subsequently treated with curative intent between 2004 and 2014. 30273205 2018
Entrez Id: 23583
Gene Symbol: SMUG1
SMUG1
0.050 Biomarker disease BEFREE The aim of this study was to investigate the prognostic significance of F-FDG uptake in salivary gland carcinoma (SGC) patients treated with definitive intensity-modulated radiation therapy (IMRT). 28650891 2017
Entrez Id: 1956
Gene Symbol: EGFR
EGFR
0.050 Biomarker disease BEFREE Patients with pN-positive salivary gland cancer may benefit from EGFR-inhibiting drugs. 26245271 2016
Entrez Id: 1956
Gene Symbol: EGFR
EGFR
0.050 Biomarker disease BEFREE Aberrations of MET are associated with copy number gain of EGFR and loss of PTEN and predict poor outcome in patients with salivary gland cancer. 23242174 2013
Entrez Id: 1956
Gene Symbol: EGFR
EGFR
0.050 AlteredExpression disease BEFREE Loss of PTEN is associated with elevated EGFR and HER2 expression and worse prognosis in salivary gland cancer. 22240798 2012
Entrez Id: 1956
Gene Symbol: EGFR
EGFR
0.050 Biomarker disease BEFREE Overall, overexpression and increased gene copy number of EGFR and HER2 characterize high-grade malignancy with unfavorable prognosis in salivary gland cancer. 22154363 2012
Entrez Id: 1956
Gene Symbol: EGFR
EGFR
0.050 GeneticVariation disease BEFREE Detection of drug-sensitizing EGFR exon 19 deletion mutations in salivary gland carcinoma. 18542074 2008
Entrez Id: 367
Gene Symbol: AR
AR
0.040 Biomarker disease BEFREE First Line Androgen Deprivation Therapy vs. Chemotherapy for Patients With Androgen Receptor Positive Recurrent or Metastatic Salivary Gland Carcinoma-A Retrospective Study. 31428578 2019
Entrez Id: 367
Gene Symbol: AR
AR
0.040 Biomarker disease BEFREE Androgen receptor in salivary gland carcinoma: A review of an old marker as a possible new target. 29863801 2018
Entrez Id: 367
Gene Symbol: AR
AR
0.040 Biomarker disease BEFREE We conducted a single institution, open-label, single arm, phase II trial of combined androgen blockade (CAB) for androgen receptor (AR)-positive SGC. 29211833 2018
Entrez Id: 367
Gene Symbol: AR
AR
0.040 Biomarker disease BEFREE In this review, we describe the prevalence, biology, and therapeutic implications of androgen receptor signaling in salivary gland cancer. 28208703 2017
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
0.030 Biomarker disease BEFREE Significant and durable clinical benefit from trastuzumab in 2 patients with HER2-amplified salivary gland cancer and a review of the literature. 28006087 2017
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
0.030 Biomarker disease BEFREE Overall, overexpression and increased gene copy number of EGFR and HER2 characterize high-grade malignancy with unfavorable prognosis in salivary gland cancer. 22154363 2012
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
0.030 AlteredExpression disease BEFREE Loss of PTEN is associated with elevated EGFR and HER2 expression and worse prognosis in salivary gland cancer. 22240798 2012
Entrez Id: 8848
Gene Symbol: TSC22D1
TSC22D1
0.030 Biomarker disease BEFREE Separately, we identified TSC-22 cDNA as an anti-cancer drug (vesnarinone)-inducible gene in a human salivary gland cancer cell line, TYS. 15379637 2004
Entrez Id: 8848
Gene Symbol: TSC22D1
TSC22D1
0.030 AlteredExpression disease BEFREE Over-expression of TSC-22 (TGF-beta stimulated clone-22) markedly enhances 5-fluorouracil-induced apoptosis in a human salivary gland cancer cell line. 10879745 2000
Entrez Id: 8848
Gene Symbol: TSC22D1
TSC22D1
0.030 AlteredExpression disease BEFREE Down-regulation of TSC-22 (transforming growth factor beta-stimulated clone 22) markedly enhances the growth of a human salivary gland cancer cell line in vitro and in vivo. 9458104 1998
Entrez Id: 29126
Gene Symbol: CD274
CD274
0.020 Biomarker disease BEFREE Objective was to analyze the role of PD-L1 and its relation to demographic, patho-clinical and outcome parameters in salivary gland carcinoma (SGC) patients. 31484986 2019
Entrez Id: 10534
Gene Symbol: ZNRD2
ZNRD2
0.020 Biomarker disease BEFREE Loss of FHIT and p27 characterizes aggressive tumor growth and unfavorable prognosis in salivary gland cancer. 30673867 2019
Entrez Id: 353376
Gene Symbol: TICAM2
TICAM2
0.020 Biomarker disease BEFREE Loss of FHIT and p27 characterizes aggressive tumor growth and unfavorable prognosis in salivary gland cancer. 30673867 2019
Entrez Id: 51014
Gene Symbol: TMED7
TMED7
0.020 Biomarker disease BEFREE Loss of FHIT and p27 characterizes aggressive tumor growth and unfavorable prognosis in salivary gland cancer. 30673867 2019
Entrez Id: 100302736
Gene Symbol: TMED7-TICAM2
TMED7-TICAM2
0.020 Biomarker disease BEFREE Loss of FHIT and p27 characterizes aggressive tumor growth and unfavorable prognosis in salivary gland cancer. 30673867 2019